カンザス州における高血圧の臨床試験
カンザス州内の拠点で、高血圧に関する11件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- University of Kansas Medical Center, Kansas City
- Cardiovascular Research Institute of Kansas, Wichita
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT06059638EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Cotton O'Neil Clinical Research Center, Topeka
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Hutchinson
- Research Site, Kansas City
- Research Site, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Hutchinson
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Topeka
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Global Paradise System US Post Approval Study
- Ascension via Christi St. Francis, Wichita
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Alliance for Multispecialty Research, Wichita
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Alliance for Multispecialty Research, Wichita
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, El Dorado
- Vanda Investigative Site, Wichita
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- University of Kansas Medical Center, Kansas City
被験者募集中第1/2相
35歳〜65歳 · 全性別 · 2025/06/08更新 · NCT04715022Reversing Glucose and Lipid-mediated Vascular Dysfunction
- University of Kansas Medical Center, Kansas City
被験者募集中早期第1相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2025/06/05更新 · NCT04832009ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。